Results for tag: "Cravit"

The Cravit market is a segment of the antibiotics market that focuses on the development and sale of cephalosporin antibiotics. Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. Cravit is a brand name for the cephalosporin antibiotic levofloxacin, which is used to treat bacterial infections such as pneumonia, bronchitis, and sinusitis. The Cravit market is highly competitive, with many companies offering their own versions of cephalosporin antibiotics. Some of the major players in the market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and AstraZeneca. Other companies such as Novartis, Allergan, and Daiichi Sankyo also offer cephalosporin antibiotics. Show Less Read more